9. “APD371, an orally available agonist of the CB2 receptor, is an internally discovered investigational drug candidate that Arena is exploring for potential development in several indications, including pain. This compound, through its selectivity, is designed to provide pain relief without psychotropic effects and without the potential for dependence or abuse. Preclinical efficacy with APD371 has been shown in several animal models of pain.” – interesting enough for our list of health benefits of medical marijuana according to publicly traded weed companies, right?
wavebreakmedia/Shutterstock.com
